Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

Wieslawa H. Dragowska(BC Cancer Agency), Marcel B. Bally(BC Cancer Agency)

PLoS ONE

October 11, 2013

10.1371/journal.pone.0076503

Cited by 101

Related Papers

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

|Breast Cancer Research|2009|73

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

|International Journal of Nanomedicine|2017|65

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

|Oncogene|2010|49

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

|BMC Cancer|2011|28

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

|PLoS ONE|2013|28